NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1344182767|gb|PPE16916|]
View 

4-oxalomesaconate tautomerase [Escherichia coli]

Protein Classification

PrpF superfamily-containing protein( domain architecture ID 1904150)

PrpF superfamily-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PrpF super family cl42415
2-Methylaconitate cis-trans-isomerase PrpF (2-methyl citrate pathway) [Energy production and ...
9-350 0e+00

2-Methylaconitate cis-trans-isomerase PrpF (2-methyl citrate pathway) [Energy production and conversion];


The actual alignment was detected with superfamily member NF033377:

Pssm-ID: 478184  Cd Length: 347  Bit Score: 603.30  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767   9 MRGGTSRGAFLLAEHLPEDQTQRDKILMAIMGSGNDLEIDGIGGGNPLTSKVAIISRSSDPRADVDYLFAQVIVHEQRVD 88
Cdd:NF033377    1 MRGGTSKGPFFLASDLPADPAERDAVLLAAMGSPDPRQIDGIGGADPLTSKVAIVSPSTRPDADVDYLFAQVSVDEARVD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767  89 TTPNCGNMLSGVGAFAIENGLIAATSPVTRVRIRNVNTGTFIEADVQTPNGVVEYEGSARIDGVPGTAAPVALTFLNAAG 168
Cdd:NF033377   81 TAPNCGNMLAGVGPFAIERGLVPAQGGETTVRIFNVNTGQIAEATVQTPGGRVEYEGDARIDGVPGTAAPVPLNFLDAAG 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 169 TKTGKVFPTDNQIDYFDDVP--VTCIDMAMPVVIIPAEYLGKTGYELPAELDADKALLARIESIRLQAGKAMGLGDVSNM 246
Cdd:NF033377  161 SKTGALLPTGNARDVIDGVEveVTCIDNGMPVVLIRAADLGLTGYESPAELDADTALKARLEAIRLQAGPLMGLGDVSDK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 247 VIPKPVLISPAQKGGAINVRYFMPHSCHRALAITGAIAISSSCALEGTVTRQI--VPSVGYGNINIEHPSGALDVHLSNE 324
Cdd:NF033377  241 VVPKMVLVAPPRAGGAISTRYFIPHRCHASIGVTGAVSVATACLLPGSVAHGLagLPGGGRKRVSVEHPSGEFDVELELD 320
                         330       340
                  ....*....|....*....|....*..
gi 1344182767 325 GQDA-TTLRASVIRTTRKIFSGEVYLP 350
Cdd:NF033377  321 GEVAgEVTRAGLLRTARKLFDGEVFVP 347
 
Name Accession Description Interval E-value
OMA_tautomer NF033377
4-oxalomesaconate tautomerase;
9-350 0e+00

4-oxalomesaconate tautomerase;


Pssm-ID: 468005  Cd Length: 347  Bit Score: 603.30  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767   9 MRGGTSRGAFLLAEHLPEDQTQRDKILMAIMGSGNDLEIDGIGGGNPLTSKVAIISRSSDPRADVDYLFAQVIVHEQRVD 88
Cdd:NF033377    1 MRGGTSKGPFFLASDLPADPAERDAVLLAAMGSPDPRQIDGIGGADPLTSKVAIVSPSTRPDADVDYLFAQVSVDEARVD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767  89 TTPNCGNMLSGVGAFAIENGLIAATSPVTRVRIRNVNTGTFIEADVQTPNGVVEYEGSARIDGVPGTAAPVALTFLNAAG 168
Cdd:NF033377   81 TAPNCGNMLAGVGPFAIERGLVPAQGGETTVRIFNVNTGQIAEATVQTPGGRVEYEGDARIDGVPGTAAPVPLNFLDAAG 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 169 TKTGKVFPTDNQIDYFDDVP--VTCIDMAMPVVIIPAEYLGKTGYELPAELDADKALLARIESIRLQAGKAMGLGDVSNM 246
Cdd:NF033377  161 SKTGALLPTGNARDVIDGVEveVTCIDNGMPVVLIRAADLGLTGYESPAELDADTALKARLEAIRLQAGPLMGLGDVSDK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 247 VIPKPVLISPAQKGGAINVRYFMPHSCHRALAITGAIAISSSCALEGTVTRQI--VPSVGYGNINIEHPSGALDVHLSNE 324
Cdd:NF033377  241 VVPKMVLVAPPRAGGAISTRYFIPHRCHASIGVTGAVSVATACLLPGSVAHGLagLPGGGRKRVSVEHPSGEFDVELELD 320
                         330       340
                  ....*....|....*....|....*..
gi 1344182767 325 GQDA-TTLRASVIRTTRKIFSGEVYLP 350
Cdd:NF033377  321 GEVAgEVTRAGLLRTARKLFDGEVFVP 347
PrpF COG2828
2-Methylaconitate cis-trans-isomerase PrpF (2-methyl citrate pathway) [Energy production and ...
1-350 0e+00

2-Methylaconitate cis-trans-isomerase PrpF (2-methyl citrate pathway) [Energy production and conversion];


Pssm-ID: 442076  Cd Length: 373  Bit Score: 564.00  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767   1 MKKIPCVMMRGGTSRGAFLLAEHLPEDQTQRDKILMAIMGSGNDLEIDGIGGGNPLTSKVAIISRSSDPRADVDYLFAQV 80
Cdd:COG2828     3 QIKIPCVLMRGGTSKGVFFLASDLPADPAARDRLLLAVMGSPDPRQIDGLGGATSLTSKVAIVSPSTRPDADVDYLFAQV 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767  81 IVHEQRVDTTPNCGNMLSGVGAFAIENGLIAATSPVTRVRIRNVNTGTFIEADVQTPNGVVEYEGSARIDGVPGTAAPVA 160
Cdd:COG2828    83 SVDKPVVDWSGNCGNILAAVGPFAIEEGLVDAQDGETTVRIWNVNTGKIIVAHVPTPDGQVQYEGDFEIDGVPGTAAPIA 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 161 LTFLNAAGTKTGKVFPTDNQIDYFD---DVPVTCIDMAMPVVIIPAEYLGKTGYELPAELDADKALLARIESIRLQAGKA 237
Cdd:COG2828   163 LEFLDPAGSVTGALLPTGNAVDTIDvggGIEVTCIDAGMPVVFVRAADLGLTGTELPAELDADPALLARLEAIRLAAGVR 242
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 238 MGLGDVSNMVIPKPVLISPAQKGGA-----------INVRYFMPHSCHRALAITGAIAISSSCALEGTVTRQIV-PSVGY 305
Cdd:COG2828   243 MGLGDVSRPVTPKIALVAPPRDYGTssgtvkaddidILVRYFSPGKCHHAMAVTGAVCIATAAAIPGTVVNELAgGGADR 322
                         330       340       350       360
                  ....*....|....*....|....*....|....*....|....*..
gi 1344182767 306 GNINIEHPSGALDV--HLSNEGQDATTLRASVIRTTRKIFSGEVYLP 350
Cdd:COG2828   323 GEVRIGHPSGTLSVgaEVDGDGGGWTVTKAGVLRTARRLMEGEVYVP 369
PrpF pfam04303
PrpF protein; PrpF is a protein found in the 2-methylcitrate pathway. It is structurally ...
1-350 0e+00

PrpF protein; PrpF is a protein found in the 2-methylcitrate pathway. It is structurally similar to DAP epimerase and proline racemase. This protein is likely to acts to isomerize trans-aconitate to cis-aconitate.


Pssm-ID: 398133  Cd Length: 384  Bit Score: 533.67  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767   1 MKKIPCVMMRGGTSRGAFLLAEHLPEDQ----TQRDKILMAIMGSGNDL--EIDGIGGGNPLTSKVAIISRSSDPRADVD 74
Cdd:pfam04303   1 QIRIPATYMRGGTSKGVFFRLEDLPEDCrvpgTARDALLLRVIGSPDPYgkQIDGMGGGNSSTSKVVIISKSSDPDHDVD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767  75 YLFAQVIVHEQRVDTTPNCGNMLSGVGAFAIENGLI-AATSP---VTRVRIRNVNTGTFIEADVQTPNGVVEYEGSARID 150
Cdd:pfam04303  81 YLFGQVSIDEPFVDWTGNCGNLSAAVGPFAIEAGLVdAARIPhrgVTAVRIWQVNIGKTIIAHVPVPNGQVQEEGDFEID 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 151 GVPGTAAPVALTFLNAAGTKTGKVFPTDNQIDYFDD-----VPVTCIDMAMPVVIIPAEYLGKTGYELPAELDADKALLA 225
Cdd:pfam04303 161 GVPFPAAEVALEFLDPADDGTGAMFPTGNLIDDLDVpglgtIEATCINAGIPTVFVDAEALGYTGTELQEEINGDPQALA 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 226 RIESIRLQAGKAMGL-GDVSNMV----IPKPVLISPAQK----------GGAIN--VRYFMPHSCHRALAITGAIAISSS 288
Cdd:pfam04303 241 RFETLRAYGALKMGLiGRVEEMVlrqhTPKLAFVAPPQDykasggkwvsAVEIDllVRAMSMGKLHHALAGTAAVAIGSA 320
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1344182767 289 CALEGTVTRQIVPSVGYGNINIEHPSGALDVHLSNEGQDA--TTLRASVIRTTRKIFSGEVYLP 350
Cdd:pfam04303 321 AAVPGTLVNRAAGGGERTNVRFGHPSGTLDVGAEAEQQDGqwTVLRAIMSRSARILMEGWVRVP 384
 
Name Accession Description Interval E-value
OMA_tautomer NF033377
4-oxalomesaconate tautomerase;
9-350 0e+00

4-oxalomesaconate tautomerase;


Pssm-ID: 468005  Cd Length: 347  Bit Score: 603.30  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767   9 MRGGTSRGAFLLAEHLPEDQTQRDKILMAIMGSGNDLEIDGIGGGNPLTSKVAIISRSSDPRADVDYLFAQVIVHEQRVD 88
Cdd:NF033377    1 MRGGTSKGPFFLASDLPADPAERDAVLLAAMGSPDPRQIDGIGGADPLTSKVAIVSPSTRPDADVDYLFAQVSVDEARVD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767  89 TTPNCGNMLSGVGAFAIENGLIAATSPVTRVRIRNVNTGTFIEADVQTPNGVVEYEGSARIDGVPGTAAPVALTFLNAAG 168
Cdd:NF033377   81 TAPNCGNMLAGVGPFAIERGLVPAQGGETTVRIFNVNTGQIAEATVQTPGGRVEYEGDARIDGVPGTAAPVPLNFLDAAG 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 169 TKTGKVFPTDNQIDYFDDVP--VTCIDMAMPVVIIPAEYLGKTGYELPAELDADKALLARIESIRLQAGKAMGLGDVSNM 246
Cdd:NF033377  161 SKTGALLPTGNARDVIDGVEveVTCIDNGMPVVLIRAADLGLTGYESPAELDADTALKARLEAIRLQAGPLMGLGDVSDK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 247 VIPKPVLISPAQKGGAINVRYFMPHSCHRALAITGAIAISSSCALEGTVTRQI--VPSVGYGNINIEHPSGALDVHLSNE 324
Cdd:NF033377  241 VVPKMVLVAPPRAGGAISTRYFIPHRCHASIGVTGAVSVATACLLPGSVAHGLagLPGGGRKRVSVEHPSGEFDVELELD 320
                         330       340
                  ....*....|....*....|....*..
gi 1344182767 325 GQDA-TTLRASVIRTTRKIFSGEVYLP 350
Cdd:NF033377  321 GEVAgEVTRAGLLRTARKLFDGEVFVP 347
PrpF COG2828
2-Methylaconitate cis-trans-isomerase PrpF (2-methyl citrate pathway) [Energy production and ...
1-350 0e+00

2-Methylaconitate cis-trans-isomerase PrpF (2-methyl citrate pathway) [Energy production and conversion];


Pssm-ID: 442076  Cd Length: 373  Bit Score: 564.00  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767   1 MKKIPCVMMRGGTSRGAFLLAEHLPEDQTQRDKILMAIMGSGNDLEIDGIGGGNPLTSKVAIISRSSDPRADVDYLFAQV 80
Cdd:COG2828     3 QIKIPCVLMRGGTSKGVFFLASDLPADPAARDRLLLAVMGSPDPRQIDGLGGATSLTSKVAIVSPSTRPDADVDYLFAQV 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767  81 IVHEQRVDTTPNCGNMLSGVGAFAIENGLIAATSPVTRVRIRNVNTGTFIEADVQTPNGVVEYEGSARIDGVPGTAAPVA 160
Cdd:COG2828    83 SVDKPVVDWSGNCGNILAAVGPFAIEEGLVDAQDGETTVRIWNVNTGKIIVAHVPTPDGQVQYEGDFEIDGVPGTAAPIA 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 161 LTFLNAAGTKTGKVFPTDNQIDYFD---DVPVTCIDMAMPVVIIPAEYLGKTGYELPAELDADKALLARIESIRLQAGKA 237
Cdd:COG2828   163 LEFLDPAGSVTGALLPTGNAVDTIDvggGIEVTCIDAGMPVVFVRAADLGLTGTELPAELDADPALLARLEAIRLAAGVR 242
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 238 MGLGDVSNMVIPKPVLISPAQKGGA-----------INVRYFMPHSCHRALAITGAIAISSSCALEGTVTRQIV-PSVGY 305
Cdd:COG2828   243 MGLGDVSRPVTPKIALVAPPRDYGTssgtvkaddidILVRYFSPGKCHHAMAVTGAVCIATAAAIPGTVVNELAgGGADR 322
                         330       340       350       360
                  ....*....|....*....|....*....|....*....|....*..
gi 1344182767 306 GNINIEHPSGALDV--HLSNEGQDATTLRASVIRTTRKIFSGEVYLP 350
Cdd:COG2828   323 GEVRIGHPSGTLSVgaEVDGDGGGWTVTKAGVLRTARRLMEGEVYVP 369
PrpF pfam04303
PrpF protein; PrpF is a protein found in the 2-methylcitrate pathway. It is structurally ...
1-350 0e+00

PrpF protein; PrpF is a protein found in the 2-methylcitrate pathway. It is structurally similar to DAP epimerase and proline racemase. This protein is likely to acts to isomerize trans-aconitate to cis-aconitate.


Pssm-ID: 398133  Cd Length: 384  Bit Score: 533.67  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767   1 MKKIPCVMMRGGTSRGAFLLAEHLPEDQ----TQRDKILMAIMGSGNDL--EIDGIGGGNPLTSKVAIISRSSDPRADVD 74
Cdd:pfam04303   1 QIRIPATYMRGGTSKGVFFRLEDLPEDCrvpgTARDALLLRVIGSPDPYgkQIDGMGGGNSSTSKVVIISKSSDPDHDVD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767  75 YLFAQVIVHEQRVDTTPNCGNMLSGVGAFAIENGLI-AATSP---VTRVRIRNVNTGTFIEADVQTPNGVVEYEGSARID 150
Cdd:pfam04303  81 YLFGQVSIDEPFVDWTGNCGNLSAAVGPFAIEAGLVdAARIPhrgVTAVRIWQVNIGKTIIAHVPVPNGQVQEEGDFEID 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 151 GVPGTAAPVALTFLNAAGTKTGKVFPTDNQIDYFDD-----VPVTCIDMAMPVVIIPAEYLGKTGYELPAELDADKALLA 225
Cdd:pfam04303 161 GVPFPAAEVALEFLDPADDGTGAMFPTGNLIDDLDVpglgtIEATCINAGIPTVFVDAEALGYTGTELQEEINGDPQALA 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1344182767 226 RIESIRLQAGKAMGL-GDVSNMV----IPKPVLISPAQK----------GGAIN--VRYFMPHSCHRALAITGAIAISSS 288
Cdd:pfam04303 241 RFETLRAYGALKMGLiGRVEEMVlrqhTPKLAFVAPPQDykasggkwvsAVEIDllVRAMSMGKLHHALAGTAAVAIGSA 320
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1344182767 289 CALEGTVTRQIVPSVGYGNINIEHPSGALDVHLSNEGQDA--TTLRASVIRTTRKIFSGEVYLP 350
Cdd:pfam04303 321 AAVPGTLVNRAAGGGERTNVRFGHPSGTLDVGAEAEQQDGqwTVLRAIMSRSARILMEGWVRVP 384
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH